Study Stopped
Failed to include the required number of participants
The Effects of Ventilation Tubes - The SIUTIT Trial
SIUTIT
1 other identifier
interventional
31
1 country
6
Brief Summary
The prevalence of otitis media among Greenlandic children is one of the highest in the world and twenty per cent of schoolchildren have impaired hearing in the frequencies for normal speech. Yet, there are no national guidelines to ensure prevention and treatment of recurrent acute otitis media and chronic otitis media with effusion and impaired hearing in Greenlandic children. International studies from the developed part of the world have shown that otitis prone children may benefit from tubulation of the tympanic membrane. However, it is unknown if these results can be applied to Greenlandic children. This PhD project will conduct a randomised controlled trial comparing tubulation of the tympanic membrane, in Greenlandic children aged 9-36 months with recurrent acute otitis media and/or chronic otitis media with effusion, to conservative treatment. The children will be followed for two years. Outcome measures will include number of visits to health clinics, number of tympanic membrane perforations, number of episodes with acute otitis media according to medical records, Quality of life, measured by the validated questionnaires OM6 and Caregiver Impact Questionnaire, number of episodes where per oral or intravenous antibiotics have been administered according to medical records and serious adverse events The trial will be conducted in collaboration with the Greenlandic health authorities and Copenhagen Trial Unit. With this trial the investigators hope to decrease the number of episodes with acute otitis media, the number of Greenlandic children with chronic perforations of the tympanic membrane and hearing impairment and increase quality of life. The results will add important knowledge to the effect of ventilation tube treatment also in an international aspect. There are to date only less than a handful of high quality studies concerning this issue on an international basis. The study will be among the first addressing this problem among populations with high risk of otitis media and is also of interest to other indigenous populations and the developing part of the world.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2016
Longer than P75 for not_applicable
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 3, 2015
CompletedFirst Posted
Study publicly available on registry
July 3, 2015
CompletedStudy Start
First participant enrolled
February 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 2, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 2, 2020
CompletedNovember 4, 2020
November 1, 2020
4.8 years
June 3, 2015
November 2, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Number of visits to health clinic
Assessed by investigating medical records.
Two years after randomisation
Secondary Outcomes (4)
Number of episodes of acute otitis media
Two years after randomisation
Quality of life
Assessed at baseline, three months after randomisation, one year after randomisation, and at the end of the trial two years after randomisation
Number of episodes where per oral or intravenous antibiotics have been administered
Two years after randomisation
Proportion of children with uni- or bilateral tympanic membrane perforations
Two years after randomisation
Other Outcomes (2)
Number of episodes of aural discharge
Two years after randomisation
Serious adverse events
During the trial
Study Arms (2)
Ventilation tube treatment
EXPERIMENTALVentilation tube insertion in the tympanic membrane
Conservative treatment
NO INTERVENTIONConventional treatment
Interventions
Tympanostomy
Eligibility Criteria
You may qualify if:
- Children aged 9-36 months.
- Children with at least one Greenlandic born parent with at least one Greenlandic born parent
- American Society of Anaesthesiologists physical status classification class 1 and 2
- B- or C2 - type curve measured by tympanometry at two visits three-four months apart or three episodes of acute otitis media in six months according to medical records or four episodes of acute otitis media in 12 months according to medical records
You may not qualify if:
- Children with orofacial cleft, Downs syndrome or known generalised immune deficiency
- American Society of Anaesthesiologists physical status classification class \> 2.
- Lack of signed informed consent, signed by the legal guardian.
- Description of experimental and control intervention Experimental intervention: The intervention group will be treated with bilateral Donaldson ventilation tubes administered in general anaesthesia Control intervention: The control intervention is based on the current practice in Greenland, which includes systemic antibiotic treatment as well as aural toilette and topical antibiotics. Ventilation tube insertion during the study period is not accepted in the control group.
- Children in the intervention group as well as the control group will be seen once a year by the visiting ear-nose-and throat (ENT)-specialist and have a final consultation after at least two years after randomisation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (6)
Aasiaat Regional Hospital
Aasiaat, Danmark, 3950, Greenland
Ilulissat Regional Hospital
Ilulissat, Danmark, 3952, Greenland
Nuuk Health Center
Nuuk, Danmark, 3900, Greenland
Sisimiut Regional Hospital
Sisimiut, Danmark, 3912, Greenland
Tasiilaq Health Center
Tasiilaq, Danmark, 3913, Greenland
Qaqortoq Regional Hospital
Qaqortoq, 3920, Greenland
Related Publications (2)
MacKeith S, Mulvaney CA, Galbraith K, Webster KE, Connolly R, Paing A, Marom T, Daniel M, Venekamp RP, Rovers MM, Schilder AG. Ventilation tubes (grommets) for otitis media with effusion (OME) in children. Cochrane Database Syst Rev. 2023 Nov 15;11(11):CD015215. doi: 10.1002/14651858.CD015215.pub2.
PMID: 37965944DERIVEDDemant MN, Jensen RG, Jakobsen JC, Gluud C, Homoe P. The effects of ventilation tubes versus no ventilation tubes for recurrent acute otitis media or chronic otitis media with effusion in 9 to 36 month old Greenlandic children, the SIUTIT trial: study protocol for a randomized controlled trial. Trials. 2017 Jan 19;18(1):30. doi: 10.1186/s13063-016-1770-x.
PMID: 28103950DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Malene N Demant, MD
Køge University Hospital
- STUDY DIRECTOR
Preben Homoe, MD, PhD
Køge University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD-student
Study Record Dates
First Submitted
June 3, 2015
First Posted
July 3, 2015
Study Start
February 1, 2016
Primary Completion
November 2, 2020
Study Completion
November 2, 2020
Last Updated
November 4, 2020
Record last verified: 2020-11
Data Sharing
- IPD Sharing
- Will share
The final dataset will be publically available in depersonalised format after the end of trial on the Danish Data Archive and ZENODO.